Dr. Holzbeierlein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3901 Rainbow Blvd
Stop 3016
Kansas City, KS 66160Phone+1 913-588-6147Fax+1 913-588-7625
Education & Training
- Vanderbilt University Medical CenterResidency, Urology, 1996 - 2000
- University of Tennessee College of Medicine (Nashville)Residency, Surgery, 1994 - 1996
- University of Oklahoma College of MedicineClass of 1994
Certifications & Licensure
- KS State Medical License 2002 - 2025
- MO State Medical License 2010 - 2025
- NY State Medical License 2000 - 2002
- American Board of Urology Urology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Super Doctor SuperDoctors.com
- Join now to see all
Clinical Trials
- Soy Derivatives for Control of Hot Flashes in Men on Androgen Deprivation Therapy Start of enrollment: 2004 Aug 01
- 177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer Start of enrollment: 2009 Jun 01
- Evaluation of Lithium and It's Effect on Clinically Localized Prostate Cancer Start of enrollment: 2014 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 217 citationsMulticenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder CancerHomayoun Zargar, Patrick Espiritu, Adrian Fairey, Laura S. Mertens, Colin P.N. Dinney
European Urology. 2015-02-01 - 572 citationsARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate CancerAndrew J. Armstrong, Russell Z. Szmulewitz, Daniel P. Petrylak, Jeffrey M. Holzbeierlein, Arnauld Villers
Journal of Clinical Oncology. 2019-07-22 - 32 citationsThe prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy.Anna J. Black, Homayoun Zargar, Kamran Zargar-Shoshtari, Adrian Fairey, Laura S. Mertens
Urologic Oncology. 2020-01-01
Press Mentions
- Spotlight: Dr. Susan Lee, MDMay 22nd, 2024
- AUA/SUO Release an Amendment to the Advanced Prostate Cancer GuidelineMay 2nd, 2023
- AUA/SUO Release an Amendment to the Advanced Prostate Cancer GuidelineApril 25th, 2023
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: